基因研究的结果并不是确定的,对于意义不确定的变异,需要进一步的研究来阐明其含义。

深入检查患者的表型(深度表型分析)。
  • 儿科遗传疾病的表型可能会随着时间的推移而发生变化,因此临床随访可以在未来提供相关信息,从而使变异能够重新分类。
  • 由于遗传学实验室的致病性解释使用标准化表型编码系统,因此使用 HPO 术语 进行描述,从而为遗传学家提供更多信息进行分析。
进行家庭隔离研究。

对家庭隔离的研究可以得出几种可能的结果:

亲本研究证实该变异是新生的。

如果亲属没有症状,在常染色体显性遗传或 X 连锁遗传基因中检测到新发变异(通过生化确认亲子关系,可以排除错误归因的可能性),该基因以前曾涉及类似的表型,会增强其致病性。然而,有必要记住,所有人的基因组中都携带大约 80-100 个从头突变,其中 1-2 个可能存在于外显子组中。

父母研究证实该变异是从无症状父母遗传的。

在某些情况下,证明该变异是从无症状父母遗传而来的,可以加强其良性。然而,必须谨慎解释此信息,特别是在呈现可变外显率的常染色体显性遗传基因中,在这种情况下,此信息不会修改致病性分类。

亲本研究证实该变异与家族中的表型分离。

在实践中,如果我们只对父母进行研究,很难证明这一发现不是偶然发生的,除非我们有很大的谱系,并且我们能够研究几代家庭中的多个成员,包括受影响的和未受影响的。

亲本研究证实该变异是先前鉴定的致病变异的反式。

如果所涉及的基因属于常染色体隐性遗传,并且我们发现了两种遗传变异,但只有其中一种可以归类为致病性或可能致病性,则进行家族研究可能会有所帮助,给出两种可能的结果:

  • 每个变体都是从父母遗传的(因此在索引病例中发现为反式),与常染色体隐性遗传兼容。
  • 两种变体均遗传自同一亲本(并且在顺式中发现,即在索引病例中在相同等位基因上),在这种情况下,发现的变体不会导致常染色体隐性遗传模式。
生化研究、功能研究和 RNA表达.
  • 如果所识别的基因具有生物标志物,例如先天性代谢缺陷的情况, 定向生化研究作为一项酶学研究,证明所识别的变体在体内产生影响。
  • 如果这是不可能的,并且怀疑变体的位置可能对剪接或 RNA表达,可以进行 RNA 测序研究来证实这一点。
  • 在拥有基础研究小组或与其有联系的中心,可以对生物仿制药、基因敲除或其他实验技术进行功能研究。
定期重新分析数据库。

遗传变异的分类过程是动态的,取决于分析时可用的信息,但信息的快速积累可能会导致解释的变化,如果在一段时间后进行重新分析的话。据估计,10%的意义不确定的变异可以在2年后的重新分析中被重新分类,并成为致病性或可能致病性。

有几个 检查当前分类的工具 基于更新数据的VSI。

根据先前的致病性分类,概率也不相等:

19955111 {19955111:7P4AN7TX} 1 温哥华 50 默认 1822 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%227P4AN7TX%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Karbassi%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BKarbassi%20I%2C%20Maston%20GA%2C%20Love%20A%2C%20DiVincenzo%20C%2C%20Braastad%20CD%2C%20Elzinga%20CD%2C%20et%20al.%20A%20Standardized%20DNA%20Variant%20Scoring%20System%20for%20Pathogenicity%20Assessments%20in%20Mendelian%20Disorders.%20Human%20Mutation%20%5BInternet%5D.%202016%20%5Bcited%202022%20Sept%2022%5D%3B37%281%29%3A127%26%23x2013%3B34.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fhumu.22918%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fhumu.22918%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Standardized%20DNA%20Variant%20Scoring%20System%20for%20Pathogenicity%20Assessments%20in%20Mendelian%20Disorders%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Izabela%22%2C%22lastName%22%3A%22Karbassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20A.%22%2C%22lastName%22%3A%22Maston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Love%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%22%2C%22lastName%22%3A%22DiVincenzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corey%20D.%22%2C%22lastName%22%3A%22Braastad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20D.%22%2C%22lastName%22%3A%22Elzinga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20R.%22%2C%22lastName%22%3A%22Bright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Domenic%22%2C%22lastName%22%3A%22Previte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ke%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20M.%22%2C%22lastName%22%3A%22Rowland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michele%22%2C%22lastName%22%3A%22McCarthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Lapierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felicita%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katelyn%20A.%22%2C%22lastName%22%3A%22Medeiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sat%20Dev%22%2C%22lastName%22%3A%22Batish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khalida%22%2C%22lastName%22%3A%22Liaquat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carol%20A.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malgorzata%22%2C%22lastName%22%3A%22Jaremko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhenyuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weimin%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%22%2C%22lastName%22%3A%22Buller-Burckle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20M.%22%2C%22lastName%22%3A%22Strom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20B.%22%2C%22lastName%22%3A%22Keiles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20J.%22%2C%22lastName%22%3A%22Higgins%22%7D%5D%2C%22abstractNote%22%3A%22We%20developed%20a%20rules-based%20scoring%20system%20to%20classify%20DNA%20variants%20into%20five%20categories%20including%20pathogenic%2C%20likely%20pathogenic%2C%20variant%20of%20uncertain%20significance%20%28VUS%29%2C%20likely%20benign%2C%20and%20benign.%20Over%2016%2C500%20pathogenicity%20assessments%20on%2011%2C894%20variants%20from%20338%20genes%20were%20analyzed%20for%20pathogenicity%20based%20on%20prediction%20tools%2C%20population%20frequency%2C%20co-occurrence%2C%20segregation%2C%20and%20functional%20studies%20collected%20from%20internal%20and%20external%20sources.%20Scores%20were%20calculated%20by%20trained%20scientists%20using%20a%20quantitative%20framework%20that%20assigned%20differential%20weighting%20to%20these%20five%20types%20of%20data.%20We%20performed%20descriptive%20and%20comparative%20statistics%20on%20the%20dataset%20and%20tested%20interobserver%20concordance%20among%20the%20trained%20scientists.%20Private%20variants%20defined%20as%20variants%20found%20within%20single%20families%20%28n%20%3D%205%2C182%29%2C%20were%20either%20VUS%20%2880.5%25%3B%20n%20%3D%204%2C169%29%20or%20likely%20pathogenic%20%2819.5%25%3B%20n%20%3D%201%2C013%29.%20The%20remaining%20variants%20%28n%20%3D%206%2C712%29%20were%20VUS%20%2838.4%25%3B%20n%20%3D%202%2C577%29%20or%20likely%20benign%5C%2Fbenign%20%2834.7%25%3B%20n%20%3D%202%2C327%29%20or%20likely%20pathogenic%5C%2Fpathogenic%20%2826.9%25%2C%20n%20%3D%201%2C808%29.%20Exact%20agreement%20between%20the%20trained%20scientists%20on%20the%20final%20variant%20score%20was%2098.5%25%20%5B95%25%20confidence%20interval%20%28CI%29%20%2898.0%2C%2098.9%29%5D%20with%20an%20interobserver%20consistency%20of%2097%25%20%5B95%25%20CI%20%2891.5%2C%2099.4%29%5D.%20Variant%20scores%20were%20stable%20and%20showed%20increasing%20odds%20of%20being%20in%20agreement%20with%20new%20data%20when%20re-evaluated%20periodically.%20This%20carefully%20curated%2C%20standardized%20variant%20pathogenicity%20scoring%20system%20provides%20reliable%20pathogenicity%20scores%20for%20DNA%20variants%20encountered%20in%20a%20clinical%20laboratory%20setting.%22%2C%22date%22%3A%222016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fhumu.22918%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fhumu.22918%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221098-1004%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%2284TR57I6%22%5D%2C%22dateModified%22%3A%222026-05-09T06%3A19%3A52Z%22%7D%7D%5D%7D
1.
Karbassi I、Maston GA、Love A、DiVincenzo C、Braastad CD、Elzinga CD 等。用于孟德尔疾病致病性评估的标准化 DNA 变异评分系统。人类突变[互联网]。 2016 年 [引自 2022 年 9 月 22 日];37(1):127–34。可从: https://onlinelibrary.wiley.com/doi/abs/10.1002/humu.22918
19955111 {19955111:IZ7ZPLNJ} 1 温哥华 50 默认 1822 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IZ7ZPLNJ%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22parsedDate%22%3A%222022-09-22%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BNothing%26%23x2019%3Bs%20for%20sure%2C%20that%26%23x2019%3Bs%20for%20sure%3A%20Evaluating%20variants%20of%20uncertain%20significance%20%7C%20Beyond%20the%20Ion%20Channel%20%5BInternet%5D.%202022%20%5Bcited%202022%20Sept%2022%5D.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fepilepsygenetics.net%5C%2F2016%5C%2F08%5C%2F11%5C%2Fnothings-for-sure-thats-for-sure-evaluating-variants-of-uncertain-significance%5C%2F%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fepilepsygenetics.net%5C%2F2016%5C%2F08%5C%2F11%5C%2Fnothings-for-sure-thats-for-sure-evaluating-variants-of-uncertain-significance%5C%2F%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22blogPost%22%2C%22title%22%3A%22Nothing%5Cu2019s%20for%20sure%2C%20that%5Cu2019s%20for%20sure%3A%20Evaluating%20variants%20of%20uncertain%20significance%20%7C%20Beyond%20the%20Ion%20Channel%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22blogTitle%22%3A%22%22%2C%22date%22%3A%222022-09-22%2017%3A29%3A43%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fepilepsygenetics.net%5C%2F2016%5C%2F08%5C%2F11%5C%2Fnothings-for-sure-thats-for-sure-evaluating-variants-of-uncertain-significance%5C%2F%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22en-US%22%2C%22collections%22%3A%5B%22B4B6FZGE%22%5D%2C%22dateModified%22%3A%222026-05-09T09%3A35%3A10Z%22%7D%7D%5D%7D
1.
没有什么是确定的,这是确定的:评估具有不确定意义的变体 |超越离子通道[互联网]。 2022 年 [引自 2022 年 9 月 22 日]。可从: http://epilepsygenetics.net/2016/08/11/nothings-for-sure-thats-for-sure-evaluating-variants-of-uncertain-significance/